Commentary: 'Smoking and lung cancer' - The embryogenesis of modern epidemiology

International Journal of Epidemiology

Volumn 38, Issue 5, 2009, Pages 1193-1196

  Vandenbroucke, Jan P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC RECEPTOR;

ATTRIBUTABLE RISK; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARCINOGENICITY; CARCINOMA IN SITU; CAUSAL ATTRIBUTION; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; GENETIC VARIABILITY; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SIGMOIDOSCOPY;

BIOMEDICAL RESEARCH; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISTORY, 20TH CENTURY; HUMANS; LUNG NEOPLASMS; SMOKING;

EID: 70349882133     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyp292     Document Type: Note

References (20)

1. Cornfield J, Haenszel, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL. Smoking and lung cancer: Recent evidence and a discussion of some questions. J Natl Cancer Inst 1959;22:173-203.
2. Rosenbaum PR. Observational Studies 2002. New York: Springer, 2002, pp. 105-6.
3. Glasziou P, Chalmers I, Rawlins M, McCulloch P. When are randomised trials unnecessary? Picking signal from noise. BMJ 2007;334 349-51.
4. Taubes G. Epidemiology faces its limits. Science 1995;269: 164-69.
5. Rosenbaum PR. Discussing hidden bias in observational studies. Ann Intern Med 1991;115:901-5.
6. Vandenbroucke JP, von Elm E, Altman DG et al. STROBE Initiative. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. PLoS Med 2007;4:297.
7. Rothman KJ. Epidemiology, An Introduction. Oxford: Oxford University Press, 2002, p. 11.
8. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. 3rd edn. Wolters Kluwer: Lippincott Williams and Williams, 2008, pp. 10-13, 27-28.
9. Weiss NS. Can the "specificity" of an association be rehabilitated as a basis for supporting a causal hypothesis? Epidemiology 2002; 13:6-8.
10. Carmelli D, Page WF. Twenty-four year mortality in World War II US male veteran twins discordant for cigarette smoking. Int J Epidemiol 1996;25:554-59.
11. Freathy RM, Ring SM, Shields B et al. A common genetic variant in the 15q24 nicotinic acetylcholine receptor gene cluster (CHRNA5-CHRNA3-CHRNB4) is associated with a reduced ability of women to quit smoking in pregnancy. Hum Mol Genet 2009;18:2922-27.
12. Vandenbroucke JP. 175th anniversary lecture. Medical journals and the shaping of medical knowledge. Lancet 1998;352:2001-6.
13. http://www.britannica.com/bps/additionalcontent/18/35778459/ GALILEO-BRUNO-AND-THE-RHETORIC-OF-DIALOGUE-IN-SEVENTEENTHCENTURY- NATURAL-PHILOSOPHY (22 July 2009, date last accessed).
14. Vineis P. Viewpoint: The skeptical epidemiologist. Int J Epidemiol 2009;38:675-77.
15. Ong EK, Glantz SA. Tobacco industry efforts subverting International Agency for Research on Cancer's secondhand smoke study. Lancet 2000;355:1253-59.
16. http://en.wikipedia.org/wiki/Artificial_controversy (22 July 2009, date last accessed).
17. The enhancement of the scientific process and transparency of observational epidemiology studies, Workshop proposed by chemical industry. http://www.ecetoc.org/index.php?mact= XtendedCalendar,cntnt01,details,0&cntnt01documentid= 24&cntnt01returnid=108 (22 July 2009, date last accessed).
18. Cornfield J. The university Group Diabetes Program. A further statistical analysis of the mortality findings. JAMA 1971;217 1671-87.
19. Psaty BM, Furberg CD. The record on rosiglitazone and the risk of myocardial infarction. N Engl J Med 2007;357: 67-69.
20. Greenhouse SW. Cornfield's contributions to epidemiology. Biometrics 1982;38:33-45.